 | Up a level |
Stucki, A; Cottagnoud, M; Acosta, F; Egerman, U; Laeuffer, JM; Cottagnoud, P (2012). Efficacy of doripenem against escherichia coli and klebsiella pneumoniae in experimental meningitis. Journal of antimicrobial chemotherapy, 67((3)), pp. 661-5. Oxford: Oxford University Press 10.1093/jac/dkr482
Egermann, U; Stanga, Z; Ramin, A; Acosta, F; Stucki, A; Gerber, P; Cottagnoud, M; Cottagnoud, Ph (2009). Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrobial agents and chemotherapy, 53(7), pp. 3030-3. Washington, D.C.: American Society for Microbiology 10.1128/AAC.00952-08
Stucki, A; Cottagnoud, M; Winkelmann, V; Schaffner, T; Cottagnoud, P (2007). Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall. Antimicrobial agents and chemotherapy, 51(6), pp. 2249-52. Washington, D.C.: American Society for Microbiology 10.1128/AAC.01000-06
Cottagnoud, P; Gerber, CM; Majcherczyk, PA; Acosta, F; Cottagnoud, M; Neftel, K; Moreillon, P; Täuber, MG (2003). The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis. Infection and immunity, 71(6), pp. 3663-6. New York, N.Y.: American Society for Microbiology 10.1128/IAI.71.6.3663-3666.2003
Cottagnoud, P; Pfister, M; Cottagnoud, M; Acosta, F; Täuber, MG (2003). Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 47(6), pp. 1943-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.47.6.1943-1947.2003
Cottagnoud, P; Cottagnoud, M; Täuber, MG (2003). Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrobial agents and chemotherapy, 47(1), pp. 144-7. Washington, D.C.: American Society for Microbiology 10.1128/ACC.47.1.144-147.2003
Cottagnoud, P; Acosta, F; Cottagnoud, M; Täuber, MG (2002). Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 46(5), pp. 1607-9. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.5.1607-1609-2002
Cottagnoud, P; Acosta, F; Cottagnoud, M; Täuber, MG (2002). Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis. Journal of antimicrobial chemotherapy, 49(2), pp. 327-30. Oxford: Oxford University Press 10.1093/jac/49.2.327
Cottagnoud, P; Gerber, CM; Cottagnoud, M; Täuber, MG (2002). Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrobial agents and chemotherapy, 46(1), pp. 188-90. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.1.188-190.2002
Cottagnoud, P; Acosta, F; Cottagnoud, M; Pfister, M; Täuber, MG (2002). Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 46(1), pp. 184-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.1.184-187.2002
Cottagnoud, P; Entenza, JM; Cottagnoud, M; Que, YA; Moreillon, P; Taüber, MG (2001). Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC microbiology, 1(1), p. 9. London: BioMed Central 10.1186/1471-2180-1-9
Perrig, M; Acosta, F; Cottagnoud, M; Gerber, CM; Täuber, MG; Cottagnoud, P (2001). Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. Journal of antimicrobial chemotherapy, 47(5), pp. 701-4. Oxford: Oxford University Press 10.1093/jac/47.5.701
Cottagnoud, P; Gerber, CM; Acosta, F; Cottagnoud, M; Neftel, K; Täuber, MG (2000). Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. Journal of antimicrobial chemotherapy, 46(6), pp. 981-5. Oxford: Oxford University Press 10.1093/jac/46.6.981
Gerber, CM; Tovar, L; Cottagnoud, M; Neftel, KA; Täuber, MG; Cottagnoud, P (2000). Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model. Journal of antimicrobial chemotherapy, 46(2), pp. 249-53. Oxford: Oxford University Press 10.1093/jac/46.2.249
Cottagnoud, P; Acosta, F; Cottagnoud, M; Neftel, K; Täuber, MG (2000). Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrobial agents and chemotherapy, 44(8), pp. 2179-81. Washington, D.C.: American Society for Microbiology 10.1128/AAC.44.8.2179-2181.2000
Gerber, CM; Cottagnoud, M; Neftel, K; Täuber, MG; Cottagnoud, P (2000). Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Journal of antimicrobial chemotherapy, 45(1), pp. 63-8. Oxford: Oxford University Press 10.1093/jac/45.1.63
Gerber, CM; Cottagnoud, M; Neftel, KA; Täuber, MG; Cottagnoud, P (1999). Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain. European journal of clinical microbiology & infectious diseases, 18(12), pp. 866-70. Berlin: Springer 10.1007/s100960050421
Rodoni, D; Hänni, F; Gerber, CM; Cottagnoud, M; Neftel, K; Täuber, MG; Cottagnoud, P (1999). Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrobial agents and chemotherapy, 43(4), pp. 963-5. Washington, D.C.: American Society for Microbiology
